CLSD has been granted a new patent
Jun 26, 2024, 10:38 PM
-5.79%
What does CLSD do
Clearside Biomedical, Inc., headquartered in Alpharetta, Georgia, specializes in delivering therapies to the back of the eye using a unique suprachoroidal space (SCS) injection platform. The company, which went public in 2016, is developing products like XIPERE and collaborates with partners on other ophthalmic therapies using its SCS Microinjector.
CLSD filed a patent for "compositions comprising axitinib and methods of treating ocular disorders" on Thu, August 18, 2022. The patent was officially published on Thu, March 23, 2023.
📡️ Health Care
Patents
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.